Insiders / Cohen Fred E

Cohen Fred E

CIK 1339358personinsider

Companies

3

First seen

Jan 7, 2026

Last activity

Jun 16, 2026

Companies

Company	Role	Shares held	Peak held	Trades	Latest
Intellia Therapeutics, Inc. · NTLA	Director	216,653	216,653	3	—
CareDx, Inc. · CDNA	Director	165,060	165,060	1	—
Kyverna Therapeutics, Inc. · KYTX	Director	21,727	21,727	2	—

All securities held

5 positions · latest reported per filing

Company	Security	Shares	As of
CareDx, Inc.	Common Stock	165,060	Jun 12, 2026
Intellia Therapeutics, Inc.	Common Stock	216,653	Jun 9, 2026
Intellia Therapeutics, Inc.	Stock Option (right to buy)Derivative	13,300	Jun 9, 2026
Kyverna Therapeutics, Inc.	Common Stock	21,727	May 27, 2026
Kyverna Therapeutics, Inc.	Stock Option (right to buy)Derivative	20,582	May 27, 2026

Activity

InsidersInstitutions

This person's insider trades (Form 4), across every company.

Date	Action	Company	Value	Shares Δ	Position after	Impact
Jan 5, 2026	Buy	NTLA Intellia Therapeutics, Inc. Common Stock	$1.40M	+150K +261.08%	207,453 0.15% of shares	high
Jun 9, 2026	Grant	NTLA Intellia Therapeutics, Inc. Common Stock	$0	+9K +4.43%	216,653 0.15% of shares	low
May 27, 2026	Grant	KYTX Kyverna Therapeutics, Inc. Common Stock	$0	+5K +30.62%	21,727 0.04% of shares	low
Jun 12, 2026	Grant	CDNA CareDx, Inc. Common Stock	$0	+10K +6.31%	165,060 0.32% of shares	low
Jun 9, 2026	Grant	NTLA Intellia Therapeutics, Inc. Stock Option (right to buy)	—	+13K	13,300 <0.01% of shares	low
May 27, 2026	Grant	KYTX Kyverna Therapeutics, Inc. Stock Option (right to buy)	—	+21K	20,582 0.03% of shares	low